QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Oliviero, S Articles by Spiegelman, B M Search for Related Content PubMed PubMed Citation Articles by Oliviero, S Articles by Spiegelman, B M Social Bookmarking                   What's this?

Research Papers

Yeast GCN4 as a probe for oncogenesis by AP-1 transcription factors: transcriptional activation through AP-1 sites is not sufficient for cellular transformation.

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115.

Abstract

The Jun and Fos oncoproteins belong to the AP-1 family of transcriptional activators and are believed to induce cellular transformation by inappropriately activating genes involved in cell replication. To determine whether transcriptional activation through AP-1 sites is sufficient for transforming activity, we examined the properties of an autonomous and heterologous AP-1 protein, yeast GCN4, in rat embryo fibroblasts. GCN4 induces transcriptional activation through AP-1 sites but, unlike Jun and Fos, fails to induce cellular transformation, in cooperation with Ha-ras. Jun-GCN4 and Fos-GCN4 homodimers independently induce cellular transformation indicating that the amino-terminal regions of Jun and Fos each contain regulatory functions that are required for oncogenesis but are distinct from generic transcriptional activation domains. In addition, these observations have implications for the nature of the oncogenically relevant target genes that respond to Jun and Fos.

CiteULike

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. Bayly and D. P. LeBrun Role for Homodimerization in Growth Deregulation by E2a Fusion Proteins Mol. Cell. Biol., August 15, 2000; 20(16): 5789 - 5796. [Abstract] [Full Text]

				P. K. Vogt, M. Aoki, I. Bottoli, H.-W. Chang, S.-l. Fu, A. Hecht, J. S. Iacovoni, B.-H. Jiang, and U. Kruse A Random Walk in Oncogene Space: The Quest for Targets Cell Growth Differ., December 1, 1999; 10(12): 777 - 784. [Full Text]

				S.-l. Fu, I. Bottoli, M. Goller, and P. K. Vogt Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation PNAS, May 11, 1999; 96(10): 5716 - 5721. [Abstract] [Full Text] [PDF]

				F. Galvagni, E. Cartocci, and S. Oliviero The Dystrophin Promoter Is Negatively Regulated by YY1 in Undifferentiated Muscle Cells J. Biol. Chem., December 11, 1998; 273(50): 33708 - 33713. [Abstract] [Full Text] [PDF]

				M. Orlandini, F. Semplici, R. Ferruzzi, F. Meggio, L. A. Pinna, and S. Oliviero Protein Kinase CK2alpha ' Is Induced by Serum as a Delayed Early Gene and Cooperates with Ha-ras in Fibroblast Transformation J. Biol. Chem., August 14, 1998; 273(33): 21291 - 21297. [Abstract] [Full Text] [PDF]

				U. Kruse, J. S. Iacovoni, M. E. Goller, and P. K. Vogt Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera PNAS, November 11, 1997; 94(23): 12396 - 12400. [Abstract] [Full Text] [PDF]

				P Tontonoz, E Hu, R A Graves, A I Budavari, and B M Spiegelman mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes & Dev., May 15, 1994; 8(10): 1224 - 1234. [Abstract] [PDF]

				C Nerlov and E B Ziff Three levels of functional interaction determine the activity of CCAAT/enhancer binding protein-alpha on the serum albumin promoter. Genes & Dev., February 1, 1994; 8(3): 350 - 362. [Abstract] [PDF]